Ascendis Pharma A (ASND) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ASND Annual Balance Sheets →
A period-by-period view of the balance sheet from Ascendis Pharma A to Dec 31 2024 helps clarify how Dec 31 2025's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents722.99
Current Tax Assets Current1.99
Cash & Short-term Investments723.00
Accounts receivable165.87
Inventories2.09
Inventories353.88
Other Current Assets54.09
Total Current Assets1,301.50
Equipment/Property/Plant Net171.91
Intangible AssetsAnd Goodwill52.76
Total Assets1,528.70
Liabilities
Current Tax Liabilities7.54
Short-term Debt452.13
Other Liabilities, Current572.67
Current Provisions195.28
Total Current Liabilities1,255.04
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI11.29
Other liabilities, Noncurrent432.74
Total Liabilities1,719.78
Stockholders' Equity
Other Equity-182.36
Common Stockholder's Equity-182.36
Total Stockholder's Equity-182.36
Liabilities & Stockholder's Equity1,528.70
4 historic quarters locked

Sign in to unlock the full Ascendis Pharma A balance sheet history.

About Ascendis Pharma A s Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 11, 2026
  • Source: asnd-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-046590

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI